Brief: CohBar Says Initiated Testing Of Cb5064 Analogs In Preclinical Models Of ARDS
05/05/2020 14:17
May 5 (Reuters) - CohBar Inc CWBR.O :
* COHBAR - INITIATED TESTING OF CB5064 ANALOGS IN
PRECLINICAL
MODELS OF ARDS, TO ASSESS POTENTIAL AS THERAPEUTICS FOR COVID-19
ASSOCIATED ARDS
Source text for Eikon: ID:nGNX5gD2RT
Further company coverage: CWBR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CohBar
See all newsBrief: CohBar, Inc. Q2 EPS USD -1.49
Brief: Morphogenesis And CohBar Announce Positive Results From Phase 1B Trial Of IFX-HU2.0 Personalized Cancer Vaccine, In Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) And Cutaneous Squamous Cell Carcinoma (CSCC)
U.S. STOCKS ON THE MOVE-Galecto, Pinterest, Standard Lithium
CohBar surges on merger agreement with Morphogenesis
U.S. STOCKS ON THE MOVE-Chevron, Broadcom, Williams-Sonoma